MB, Levis & Associates’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.72K | Hold |
1,041
| – | – | ﹤0.01% | 246 |
|
|
2025
Q1 | $1.65K | Hold |
1,041
| – | – | ﹤0.01% | 253 |
|
|
2024
Q4 | $3.49K | Hold |
1,041
| – | – | ﹤0.01% | 234 |
|
|
2024
Q3 | $1.96K | Hold |
1,041
| – | – | ﹤0.01% | 259 |
|
|
2024
Q2 | $2.05K | Hold |
1,041
| – | – | ﹤0.01% | 257 |
|
|
2024
Q1 | $3.2K | Hold |
1,041
| – | – | ﹤0.01% | 238 |
|
|
2023
Q4 | $2.43K | Hold |
1,041
| – | – | ﹤0.01% | 243 |
|
|
2023
Q3 | $4.21K | Hold |
1,041
| – | – | ﹤0.01% | 225 |
|
|
2023
Q2 | $4.27K | Hold |
1,041
| – | – | ﹤0.01% | 223 |
|
|
2023
Q1 | $3.21K | Sell |
1,041
-1
| -0.1% | -$3 | ﹤0.01% | 236 |
|
|
2022
Q4 | $2.81K | Buy |
+1,042
| New | +$2.81K | ﹤0.01% | 224 |
|